FDA Investigator Gary J Lehr
Gary J Lehr has inspections in 1 countries as of 10 Oct 2023. Gary J Lehr has collaborated with a combinined 1722 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
32
Last Inspection Date:
10 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alice S Tsao,
Althea A Williams,
Amatul H Marium,
Amy W Mai,
Amy W Yan Mai,
Andrew M Abramowitz,
Ann M Stewart,
Avital A Shimanovich,
Bijoy Panicker,
Brandy N Lepage,
Brenda W Uratani, PhD,
Charanjeet Jassal,
Charisse K Green,
Daniel L Zheng,
David R Delucia,
Demitria J Xiradakis,
Dennis E Guilfoyle, PhD,
Dongping Dai, PhD,
Dr. Robert C Horan, MD,
Edmund F Mrak, Jr,
Edouard Viard,
Erik W Koester,
Felix Maldonado,
Frank Verni,
Gam S Zamil,
Gary J Lader,
Gary T Greco,
Guerlain Ulysse,
Helen B Ricalde,
Irina Gaberman,
Jaison J Eapen,
James A Liubicich,
James A Liubieich,
Jay T Wong,
Jazmine N Brown,
Jazmine N Still,
Jose O Hernandez,
Joy P Matthias,
Juan Rjimenez Garcia,
Juanita P Versace,
Justin A Boyd,
Karen L Kosar,
Karishma G Gopaul,
Kazi Rafiquzzaman,
Kenneth H Williams,
Kevin A Gonzalez,
Kim Lthomas Cruse,
Kim Thomasc Rice,
Kimberly Y Smithson,
Krishna Ghosh, PhD,
Lawrence W Farina,
Marie Bbuen Bigornia,
Michael A Charles,
Michael Levin,
Mindy M Chou,
Nariman Patenaude,
Nazmul Hassan,
Neil J Bonzagni, PhD MPH,
Nerizza B Guerin,
Nicholas A Violand,
Omadevi Somai, Investigator,
Parul M Patel,
Patrick C Klotzbuecher,
Paul Mouris,
Peter Abel,
Peter Caparelli,
Peter R Caparelli,
Philip F Istafanos, DMV, MS,
Rachael A Moliver,
Ramon A Hernandez,
Rober C Horan, PhD,
Robert C Steyert,
Rochelle K Kimmel,
Samina S Khan,
Sarah A Meehan,
Sarah A Wangseng,
Satheesh Thomas,
Shari L Kahn,
Simone E Pitts,
Sony Mathews,
State Agency,
Steven M Weinman,
Susan M Joseph,
Susan W Ting,
Susant Hadman,
Suwaskie S Smith,
Tanya R Syffrard,
Terry Bridgewater,
Thomas J Arista,
Thomas J Mooney,
Thomas S Arista,
Tracy M Portelli,
Uduak M Inokon,
Valentino Fiorella,
Valerie A Potopsingh,
Vioela J Caze,
Xiaokuang Lai, PhD
Gary J Lehr's Documents
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more